|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.525 GBX | -0.55% |
|
-4.74% | -37.59% |
| Apr. 26 | EARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters Germany | AN |
| Apr. 26 | Earnings Flash (ROQ.L) ROQUEFORT THERAPEUTICS Reports FY23 Loss GBX-1.35 | MT |
Roquefort Therapeutics plc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was GBP 0.2 million. Net loss was GBP 0.782358 million compared to GBP 0.762281 million a year ago.
Basic loss per share from continuing operations was GBP 0.0064 compared to GBP 0.0205 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -37.59% | 7.32M | |
| -6.03% | 113B | |
| -3.83% | 87.91B | |
| +20.42% | 63.85B | |
| +5.29% | 61.9B | |
| +10.12% | 42.86B | |
| +7.95% | 40.84B | |
| +19.12% | 34.58B | |
| +5.88% | 25.46B | |
| -5.25% | 22.13B |
ROQUEFORT THERAPEUTICS PLC 
